Loading...
XKRX011690
Market cap49mUSD
Jan 10, Last price  
1,990.00KRW
1D
-1.00%
1Q
-28.55%
Jan 2017
-88.13%
Name

Y2 Solution Co Ltd

Chart & Performance

D1W1MN
XKRX:011690 chart
P/E
P/S
0.53
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
4.84%
Rev. gr., 5y
8.50%
Revenues
136.94b
+13.62%
90,579,522,000106,361,864,000160,765,837,000197,959,817,000150,112,681,060143,479,948,640115,749,129,490137,134,398,270127,936,189,79097,923,870,460112,119,451,25091,081,443,410108,289,227,490107,392,165,470101,522,699,260120,518,463,730136,937,717,870
Net income
-345m
L-84.40%
1,326,147,0001,926,400,0002,718,292,0001,347,785,000-5,344,675,000-1,521,437,000-4,381,099,000300,782,0001,617,386,690-5,113,503,7604,108,937,320-29,972,348,840-9,501,426,300-43,044,842,830-9,658,224,650-2,214,111,170-345,354,383
CFO
-20.35b
L+732.30%
-1,231,542,0003,347,600,0001,182,349,000-11,524,259,00032,638,895,2603,057,889,9802,048,206,2803,137,787,01014,899,284,7003,065,166,990-3,887,379,810-2,094,917,060-14,839,894,860-15,004,748,530-6,070,949,900-2,445,610,330-20,354,839,480
Dividend
Dec 29, 20102 KRW/sh

Profile

Y2 Solution CO.,LTD provides TV power supply and LED lighting services in South Korea. The company offers switching mode power supply (SMPS) module for displays used in LED TV, UHD TV, OLED TV, signage TV, etc.; and indoor and outdoor LED lighting. It also provides secondary battery cell testing systems; location-based visible light communication (VLC) systems, which provides guidance and marketing services based on location without using RF communication for shopping malls, electronic attendance-absence recording systems, indoor navigation, and Zigbee commissioning; and bi-direction VLC systems used in smart factory, hospital, RF communication error environment, etc. In addition, the company offers IoT VLC systems to smart farm, smart factory, home IoT, etc.; and high-speed VLC systems used in meeting room security system, data transmission security system, network segregate, etc. Further, it provides imports and sells petrochemical products; and develops drugs for epidermolysis bullosa, dry-amd, duchenne muscular dystrophy, and type 2 diabetes. The company was formerly known as Yuyang D&U Co., Ltd. The company was founded in 1976 and is headquartered in Hwaseong-si, South Korea.
IPO date
Dec 21, 1995
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
136,937,718
13.62%
120,518,464
18.71%
Cost of revenue
126,033,043
111,574,168
Unusual Expense (Income)
NOPBT
10,904,674
8,944,295
NOPBT Margin
7.96%
7.42%
Operating Taxes
163,712
199,121
Tax Rate
1.50%
2.23%
NOPAT
10,740,962
8,745,174
Net income
(345,354)
-84.40%
(2,214,111)
-77.08%
Dividends
Dividend yield
Proceeds from repurchase of equity
(25,064)
BB yield
0.03%
Debt
Debt current
603,563
11,319,029
Long-term debt
3,287,549
3,746,175
Deferred revenue
73
72,345
Other long-term liabilities
64,824
20
Net debt
(25,971,267)
(18,273,968)
Cash flow
Cash from operating activities
(20,354,839)
(2,445,610)
CAPEX
(2,785,621)
(4,016,478)
Cash from investing activities
4,215,255
(1,886,260)
Cash from financing activities
(1,743,292)
6,093,721
FCF
(13,187,608)
2,087,231
Balance
Cash
8,349,569
36,902,809
Long term investments
21,512,810
(3,563,637)
Excess cash
23,015,493
27,313,249
Stockholders' equity
(6,879,450)
(12,672,370)
Invested Capital
110,848,274
108,105,341
ROIC
9.81%
8.27%
ROCE
10.26%
9.16%
EV
Common stock shares outstanding
35,278
31,847
Price
2,790.00
-6.06%
2,970.00
 
Market cap
98,426,772
4.06%
94,585,967
 
EV
72,455,505
81,276,547
EBITDA
13,858,516
10,974,472
EV/EBITDA
5.23
7.41
Interest
658,084
1,787,609
Interest/NOPBT
6.03%
19.99%